BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19104030)

  • 1. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ; Stoops WW; Hays LR; Rush CR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Rush CR; Kollins SH; Pazzaglia PJ
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
    Rush CR; Baker RW
    Exp Clin Psychopharmacol; 2001 Feb; 9(1):59-73. PubMed ID: 11519636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
    Lile JA; Kelly TH; Pinsky DJ; Hays LR
    Psychopharmacology (Berl); 2009 Apr; 203(2):241-50. PubMed ID: 19018520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole.
    Sevak RJ; Vansickel AR; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2011 Aug; 31(4):470-80. PubMed ID: 21694622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
    Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
    Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.
    Heishman SJ; Henningfield JE
    Psychopharmacology (Berl); 1991; 103(4):436-42. PubMed ID: 2062984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    J Psychopharmacol; 2003 Mar; 17(1):17-29. PubMed ID: 12680736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
    Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
    Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 2007 Jun; 192(3):425-40. PubMed ID: 17342474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative-stimulus effects of modafinil in cocaine-trained humans.
    Rush CR; Kelly TH; Hays LR; Wooten AF
    Drug Alcohol Depend; 2002 Aug; 67(3):311-22. PubMed ID: 12127202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar discriminative-stimulus effects of D-amphetamine in women and men.
    Vansickel AR; Lile JA; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2007; 87(2):289-96. PubMed ID: 17561238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux.
    Desai RI; Paronis CA; Martin J; Desai R; Bergman J
    J Pharmacol Exp Ther; 2010 Jun; 333(3):834-43. PubMed ID: 20190012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.